What we do
- Member and patient community programmes
- MPE Masterclass
- Scholarship programme
- Myeloma CABs
- MPE Myeloma and AL amyloidosis Community Taskforce
- COVID-19
- Advocate Development Programme
- European Young Myeloma Patients Group
- Reasonable Agreements between Patient Advocates and Pharmaceutical Companies (RAPP)
- Research
- Access and Policy
- Educational Resources